ThermoBreast Project Patient Survey on Breast Cancer Screening Experiences
ThermoBreast EU project survey invites women to share breast screening experiences to inform development of non-invasive, radiation-free detection technology. Read More
Home »
Breast Cancer
CPE Patient Survey on Metastatic Breast Cancer Biomarkers (ESR1 and Liquid Biopsy)
CPE’s survey on ESR1 mutations and liquid biopsy awareness among metastatic breast cancer patients across 5 EU countries informed the 2025 White Paper. Read More
Bridging the Gap: Empowering Shared Decision-Making in Breast Cancer Care – Advisory Board Meeting Report (ESMO 2024)
CPE’s ESMO 2024 advisory board report examines barriers to shared decision-making in breast cancer care, with recommendations for clinicians and patient organisations. Read More
myC – My Cancer My Concern: Genomics and Breast Cancer European Patient Survey
CPE’s myC patient survey assessed genomic testing awareness in early breast cancer across 5 EU countries. Findings shaped the myC White Paper and policy recommendations. Read More
Event Report: Launch of CPE’s White Paper on ESR1 Mutations and Liquid Biopsy in Metastatic Breast Cancer at the European Parliament
CPE’s European Parliament event report on ESR1 mutations and liquid biopsy in metastatic breast cancer — key findings, MEP statements, and policy recommendations. Read More
New Biomarkers in Metastatic Breast Cancer & Awareness on ESR1 and Liquid Biopsy: Analysis of a European Patient Survey
CPE’s 2025 White Paper reveals major awareness gaps on ESR1 mutations and liquid biopsy among metastatic breast cancer patients across 5 EU countries. Read More
myC – My Cancer My Concern: Genomic Testing Survey Infographics
See the myC survey results: 4 in 5 eligible breast cancer patients weren’t told about genomic testing. View infographics for 5 European countries. Read More
Awareness of Genomic Testing Among Patients with Breast Cancer in Europe – ESMO 2023 Poster
CPE’s ESMO 2023 poster reveals only 1 in 5 eligible breast cancer patients were told about genomic testing. See the European survey data. Read More
Awareness of Genomic Testing in Breast Cancer: A Call to Action Across Europe
CPE’s myC White Paper reveals 78% of eligible breast cancer patients were never told about genomic testing. Read the Call to Action for Europe. Read More